James A Watson

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial

Peter Horby, Marion Mafham, Louise Linsell et al. · medRxiv · 2020 · 249 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Resolving the cause of recurrent Plasmodium vivax malaria probabilistically

Aimee R. Taylor, James A Watson, Cindy S. Chu et al. · Nature Communications · 2019 · 138 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +13

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

Nicholas J. White, James A Watson, Richard M. Hoglund et al. · PLoS Medicine · 2020 · 122 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

William HK Schilling, Podjanee Jittamala, James A Watson et al. · The Lancet Infectious Diseases · 2023 · 95 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria

James A Watson, Walter Taylor, Germana Bancone et al. · PLoS neglected tropical diseases · 2018 · 89 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14